Target intelligence / Profile preview

Hydroxyapatite (Tooth enamel mineral phase) (HAP)

Target
HAP
Molecular classification
Inorganic mineral, Biomineral, Calcium phosphate
01

Overview

The tooth enamel mineral phase is the most highly mineralized tissue in the human body, composed of approximately 96% inorganic material, primarily in the form of carbonated hydroxyapatite crystals [NIH/NIDCR, 2023]. Its primary biological function is to provide a hard, wear-resistant surface for mastication while protecting the underlying dentin and pulp from chemical, thermal, and mechanical insults [StatPearls, 2023]. This mineral phase is dynamic, undergoing constant cycles of demineralization and remineralization depending on the pH of the oral environment and the concentration of ions in saliva [Aoba, 2004]. Therapeutic interventions often target this phase by introducing fluoride ions, which integrate into the crystal lattice to form fluorapatite, a more stable and acid-resistant mineral [Buzalaf et al., 2011]. Failure to maintain the integrity of this mineral phase results in dental caries, the most prevalent chronic disease globally, as well as dental erosion from extrinsic or intrinsic acids [Selwitz et al., 2007]. Modern dental materials also aim to mimic this phase through biomimetic hydroxyapatite to repair early-stage lesions.

Other names
Carbonated hydroxyapatiteEnamel mineralCalcium hydroxyapatiteBioapatiteEnamel apatite
02

Mechanism of action

Promotes remineralization by facilitating the deposition of calcium and phosphate ions into the enamel matrix and substituting hydroxyl groups with fluoride to form acid-resistant fluorapatite [Aoba, 2004; StatPearls, 2023].

03

Biological functions

Structural supportMasticationProtection of dental pulpIon reservoir for calcium and phosphate
04

Disease associations

Dental cariesDental erosionEnamel hypoplasiaAmelogenesis imperfectaDental fluorosis
05

Safety considerations

Dental fluorosis (mottling during development)Skeletal fluorosis from chronic overexposureAcute toxicity if high concentrations are ingested [CDC, 2022]
06

Interacting drugs

Sodium fluoride

5 more in the full profile.

07

Biomarkers

Enamel mineral density (Micro-CT)Surface microhardnessLaser fluorescence (DIAGNOdent)Quantitative light-induced fluorescence (QLF)

Beyond the preview

Go deeper on Hydroxyapatite (Tooth enamel mineral phase) (HAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite (Tooth enamel mineral phase) (HAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call